Burcon Nutrascience Corp Stock Price, News & Analysis

Burcon NutraScience (OTCQB: BRCNF) reported its fiscal 2025 results, marking a transformative year in its transition from innovation to commercial execution. The company recorded revenue of $381,000 and a net loss of $8.3 million ($1.06 per share). Key achievements include forming a strategic alliance with ProMan for the Galesburg protein facility acquisition, raising $9.4 million through a rights offering, and securing a $6.8 million multi-year production agreement.

The company launched several new protein products including Puratein®C canola protein, Peazazz®C pea protein, and Solatein™ sunflower protein. With over 100 prospective customers evaluating their proteins, Burcon targets $1-3 million revenue for calendar 2025 and expects profitability by calendar 2026. The company ended the fiscal year with $7.3 million in cash.

Burcon NutraScience Corporation (BRCNF) has secured a significant multi-year production agreement worth $6.8 million with a leading provider of clean label, plant-based ingredients. The agreement will generate minimum annual revenue of $1.4 million in the first year, with production already initiated in the current quarter and expected to scale up in the latter half of 2025. CEO Kip Underwood highlighted this as a major step toward profitability, supporting the company's 2025 revenue targets. The contract manufacturing services at Burcon's Galesburg facility represent a strategic move to diversify revenue streams while delivering plant-based solutions to customers.

Burcon NutraScience Corporation (BRCNF), a global leader in plant-based protein innovation, has scheduled its fiscal year 2025 conference call and webcast for June 25, 2025, at 5:00 p.m. Eastern time. The company will discuss its financial results for the fiscal year ended March 31, 2025, with results to be released prior to the call. CEO Kip Underwood highlighted that Burcon is at a crucial transition phase, moving from innovation to execution while maintaining its leadership in differentiated protein technologies. The company's current focus areas include scaling production, meeting customer demand, and driving sustained commercial growth. The conference call will be accessible via webcast and through dial-in numbers for North American and international participants.

Burcon NutraScience Corporation announced its participation in the IFT FIRST Annual Meeting and Exposition in Chicago from July 13-16, 2025, where it will showcase its portfolio of high-purity plant protein ingredients at booth S4066. The company will present its suite of 90%+ protein purity products including Peazazz C (pea protein), Puratein C (canola protein), Solatein (sunflower protein), HPI95 (hempseed protein), and will unveil FavaPro, a new high-purity fava protein ingredient. CEO Kip Underwood emphasized the company's focus on meeting consumer demands for taste, nutrition, and sustainability in plant-based foods. Visitors will have the opportunity to sample a plant-based beverage featuring Burcon's proprietary blend of pea and sunflower protein.

Burcon NutraScience (BRCNF) has achieved its first commercial production of Peazazz C pea protein at its Galesburg facility in Illinois. The company expects revenues of $1-3M in 2025 and over $10M in 2026, with positive cash flow projected for 2026. Additionally, Burcon announced a 20:1 share consolidation effective June 11, 2025, aimed at improving share marketability and attracting new investors. The consolidation will reduce the number of outstanding shares from 253,761,444, with fractional shares being rounded up if 0.5 or greater and down if less than 0.5. The company's management views this milestone as crucial for meeting customer demand and generating scalable revenue opportunities, while the consolidation is expected to optimize capital structure and enhance long-term shareholder value.

Burcon NutraScience Corporation (BRCNF), a leader in plant-based protein technology, has been invited to present at the 2025 Canadian Climate Investor Conference (CCIC) on June 11, 2025 in Toronto. CEO Kip Underwood will showcase Burcon's sustainability initiatives and growth potential, particularly highlighting their upcoming commercial production launch. The CCIC, hosted by TSX and TSXV, aims to connect clean technology companies with climate-conscious investors to accelerate sustainable development in Canada.

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed the installation and commissioning of its proprietary protein processing equipment at its Galesburg, Illinois facility. The integration was accomplished in just 10 days through collaboration with RE ProMan

The Galesburg facility, a certified commercial food processing site, has been equipped with new piping, electrical systems, and proprietary equipment aligned with Burcon's core protein technology platform. This development positions the company to:

• Scale up production
• Optimize operations
• Advance commercial partnerships
• Launch its complete portfolio of protein products

Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) announces that its alliance partner, RE ProMan, , has completed the acquisition of a protein production facility in Galesburg, Illinois. The facility was chosen for its strategic location near agricultural growers and key transportation routes, as well as its existing processing capabilities that align with Burcon's protein technology platform.

The company plans to integrate its proprietary technologies into the facility and expects to begin commercial-scale production of protein products during the first half of 2025. This acquisition represents Burcon's first operational control of a commercial facility, positioning the company to deliver sustainable plant-based protein solutions to meet market demand.

Burcon NutraScience has successfully completed a rights offering, raising $9.43 million through the issuance of 110,986,126 common shares at $0.085 per share. The offering received strong support from strategic investors, including management and board members.

A total of 77,198,140 shares were issued under basic subscription rights, with 19,061,806 shares going to insiders and 58,136,334 to other investors. Additional subscription privileges resulted in 33,787,986 shares being issued. Following the offering, Burcon has 253,761,444 common shares outstanding.

The Insider Group now owns 30.64% of outstanding shares. The proceeds will primarily fund Burcon's obligations under a recently announced Manufacturing Agreement with RE ProMan, , and support the commercialization and scaling of protein products.